At the completion of the complaint investigation, based on the information received, the clinical evaluation was able to confirm the reported type 3b endoleak of the proximal extension, a persistent type 3b endoleak of the main body and a type 3a endoleak.The clinical evaluation additionally found evidence to reasonably suggest the following contributing factors to the reported event; off label use, untreated endoleak type iiib of the cuff, and poor stent to stent apposition.The review of manufacturing lot confirmed all devices met specifications prior to release.The event devices have not been returned and were not available for further evaluation.The root cause of the reported event is unknown.There is not enough information to determine the root cause of the reported event at this time.To date there has been no additional information on the current patient status.
|